Genzyme Nederland
|
Genzyme Nederland Employees in Amsterdam: 415 |
Company Profile
Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Founded in Boston in 1981, Genzyme has grown from a small start-up to a diversified enterprise with annual revenues exceeding $3 billion and more than 9,500 employees in locations spanning the globe. With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. Genzyme’s European office was founded in 1991 and now harbors over 400 people. These people are involved in European clinical research, regulatory affairs, medical info, pharmacovigilance, datamanagement, marketing, sales, finance, customer services, IT and HR.Science and Technologies or Services
Genzyme’s research and development efforts are focused on the areas of medicine where it markets commercial products. The company also conducts research in cardiovascular disease and other areas of unmet medical need. In 2006, the company invested approximately $565 million in this work, or about 18 percent of its revenues. Genzyme identifies unmet medical needs and its large team of scientists and researchers uses a broad range of scientific approaches and technologies to meet those needs. The company is a leader in novel areas such as cell and gene therapies and biomaterials. Genzyme also partners with other companies to develop new products and supports research conducted by top academic and independent medical science centers.
Alliances
Genzyme has many different alliances with companies and research groups around the world. In the Netherlands Genzyme is collaborating with Macrozyme BV in the area of diabetes and scientific and clinical projects are ongoing with researchers in several academic centers, including the AMC.
Keywords
- Orphan diseases
- Renal disease
- Oncology
- Transplant
- Orthopedics
- Familial Hypercholesterolemia
